Inogen (INGN) Income from Non-Controlling Interests (2016 - 2026)
Inogen (INGN) posted quarterly Income from Non-Controlling Interests of $17000.0 for Q1 2026, up 139.53% quarter-over-quarter from -$43000.0 in Q4 2025.
Inogen (INGN) Income from Non-Controlling Interests (2016 - 2026) Analysis & Trends
Inogen (INGN) has reported Income from Non-Controlling Interests for 11 consecutive years, with $17000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests changed N/A year-over-year to $17000.0; the TTM figure through Mar 2026 stood at $39000.0 (changed N/A YoY), while the FY2025 annual figure was $22000.0, up 116.18% from the prior year.
- Income from Non-Controlling Interests rose to $17000.0 in Q1 2026 per INGN's latest filing, from -$43000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $203000.0 in Q3 2024 and bottomed at -$297000.0 in Q4 2024.
- Historically, Income from Non-Controlling Interests has averaged $2375.0 across 5 years, with a median of $13000.0 in 2022.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests jumped 1800.0% — and 2023, when it slumped 900.0%.
- Inogen's Income from Non-Controlling Interests stood at $9000.0 in 2022, then plunged by 900.0% to -$72000.0 in 2023, then slumped by 312.5% to -$297000.0 in 2024, then soared by 85.52% to -$43000.0 in 2025, then surged by 139.53% to $17000.0 in 2026.
- Business Quant data shows INGN's Income from Non-Controlling Interests at $17000.0 in Q1 2026, -$43000.0 in Q4 2025, and $23000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | Inogen | 151.99 Mn | 46.45 Mn | 43.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Dec 31, 2024 | -297,000.00 |
| Sep 30, 2024 | 203,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -72,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Mar 31, 2023 | 69,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Mar 31, 2022 | -8,000.00 |
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -3,000.00 |